Brief: Cyxone Orders More Rabeximod Substance And Confirms Timeline For The Phase Iib Program

Cyxone AB

29/01/2020 11:20

Jan 29 (Reuters) - Cyxone AB  CYXO.ST :
    * CYXONE ORDERS MORE RABEXIMOD SUBSTANCE AND CONFIRMS
TIMELINE FOR
THE PHASE IIB PROGRAM
    * CYXONE AB - FIRST PATIENT IS EXPECTED TO ENTER CLINICAL
PHASE
IIB TRIAL IN Q1 OF 2021

Source text for Eikon:  ID:nPn7F99Q9a 
Further company coverage:  CYXO.ST 

 ((Reuters.Briefs@thomsonreuters.com;))